Radiopharmaceutical company Fusion Pharmaceuticals Inc. is acquiring a phase II actinium-based alpha-emitter radiopharma program for prostate cancer from Radiomedix Inc.

Med-tech firms raising money in public or private financings, including: Exact Sciences.

Biopharmas raising money in public or private financings, including: Abivax, Apellis, Aprea, Omega, Transcend.

Med-tech firms raising money in public or private financings, including: Bellevue Life Sciences, Current Surgical.

Biopharmas raising money in public or private financings, including: Abilita, Apellis, Azitra, Biomx, Quoin, Sorrento.

Hemab Therapeutics ApS raised $135 million in a series B funding round to continue its broad effort to build a company focused on developing prophylactic therapies for neglected bleeding and thrombotic disorders. The new cash brings its total equity raise to $190 million.

Biopharmas in Asia-Pacific raising money in public or private financings: Glycomimetics.